IMDX
Insight Molecular Diagnostics Inc.
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +793.8% | +288.1% | -9.4% | +123.5% | +80.6% | -51.5% | -61.4% | -37.6% | -71.7% | +343.3% | +55.9% | -7.3% | -59.0% | -40.9% | +10.6% | +1,192.2% | +43.9% | -75.8% | -49.8% | +338.1% | -97.2% | +646.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +111.0% | +64.7% | +19.1% | +45.9% | +132.0% | -23.7% | -92.8% | +54.9% | +63.1% | -14.6% | -33.4% | -5.2% | -27.6% | -58.8% | +20.4% | +1,270.8% | -8.8% | -79.3% | -28.0% | +431.4% | -0.9% | -87.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -598.7% | – | – | -87.4% | -967.7% | – | +2,620.0% | -8.8% | -81.9% | +11.1% | +0.0% | +1,090.0% | +122.7% | -73.6% | -60.3% | +256.8% | -222.1% | – | – | |
| – | -0.7% | -20.7% | +23.5% | +54.4% | -29.2% | +14.1% | +5.0% | +28.2% | +8.9% | -8.1% | -20.4% | +58.9% | -34.2% | -12.0% | +12.3% | +7.8% | +32.9% | +49.4% | -18.9% | -31.2% | +86.7% | -24.5% | +23.8% | -36.1% | +21.8% | -39.8% | +44.5% | +14.5% | -10.3% | +5.8% | +6.1% | +14.8% | -19.9% | +29.6% | +12.2% | +18.2% | +50.3% | -21.1% | -2.5% | – | |
| – | -33.0% | +107.6% | +152.8% | -5.3% | -14.2% | -0.4% | +5.4% | +82.4% | -45.4% | +284.7% | -58.3% | -25.3% | -1.7% | +86.7% | +48.5% | -17.4% | +54.1% | -18.7% | +32.9% | -31.7% | +39.7% | +65.6% | +2.1% | -26.6% | -7.8% | +1.8% | -26.7% | -7.1% | -17.7% | +8.7% | -28.7% | +6.6% | +23.2% | -1.4% | -15.0% | -3.9% | +57.1% | -25.2% | -3.9% | – | |
| – | -8.7% | +2.8% | +71.2% | +21.9% | -13.6% | +2.0% | +19.8% | +46.5% | -20.8% | +90.4% | -42.9% | +8.2% | -28.5% | +32.2% | +36.7% | -3.8% | +57.4% | +3.3% | -27.5% | -2.3% | +88.9% | +15.2% | -3.3% | -74.4% | -49.2% | -13.3% | -506.4% | – | -21.1% | +37.7% | -49.7% | +189.7% | +152.3% | -76.3% | +25.5% | +9.8% | -6.6% | -6.9% | +18.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -241.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +200.0% | +50.0% | -55.6% | +175.0% | +18.2% | -30.8% | +44.4% | +400.0% | +9.2% | -15.5% | -6.7% | -10.7% | -62.0% | +778.9% | -19.2% | -83.7% | +240.9% | +4.0% | -1.3% | -11.7% | -27.9% | +2.0% | -40.0% | -30.0% | -33.3% | -21.4% | +27.3% | +0.0% | +7.1% | -46.7% | +287.5% | -3.2% | -3.3% | -13.8% | +16.0% | -10.3% | -11.5% | -13.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -239.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -987.5% | – | – | – | – | +400.0% | – | – | -3.4% | -10.7% | -114.0% | – | – | – | – | -5,052.5% | – | – | – | – | +131.0% | -370.1% | – | +2,512.5% | +67.8% | -81.2% | +849.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -374.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -222.0% | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.